Injective CEO rings Nasdaq bell as Canary’s staked INJ ETF begins trading
Injective has entered the U.S. exchange-traded fund market after Canary Capital launched its staked INJ ETF on Nasdaq, with the fund reaching $16.12 million in net assets during its first two









